secwatch.observer — SEC 8-K summary
======================================

Issuer:     LeonaBio, Inc. (LONA)
CIK:        0001620463
Form:       8-K
Filed at:   2025-10-03T23:59:59+00:00
Accession:  0001193125-25-229293
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
LLM model:  deepseek-v4-flash:cloud@v2

Athira Pharma regains Nasdaq minimum bid price compliance; delisting risk removed
--------------------------------------------------------------------------------

- Received Nasdaq notice on Oct 2, 2025 that closing bid price was $1.00+ for ten consecutive days.
- Compliance with Nasdaq minimum bid requirement is regained and the matter is closed.
- Previously notified of deficiency on Oct 16, 2024 when stock fell below $1.00 for 30 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1620463/000119312525229293/0001193125-25-229293-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1620463/000119312525229293/atha-20251002.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-229293

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer